康诺亚生物医药科技成都有限公司
CN
 
CN
Science & Technology
Research areasDrug CandidateTarget(Modality)Focused IndicationsLead
Identification
Pre-ClinicalINDClinical TrialsPartnerCommercial Rights
AutoimmunityCM310IL-4Rα(mAb)Moderate-to-severe AD--Adults

*BTD granted by CDE


Global
Moderate-to-severe AD--Children & Adolescents

Global
CRSwNP

Global
Moderate-to-severe eosinophilic asthma
Global ex mainland
China
SAR

Global
CM326TSLP(mAb)Moderate-to-severe AD

Global
CRSwNP

Global
Moderate-to-severe asthma
Global ex mainland
China
COPD
Global ex mainland
China
CM338MASP-2(mAb)IgA nephropathy

Global
OncologyCMG901

*FTD & ODD granted by FDA
*BTD granted by CDE

Claudin 18.2
(ADC)
Gastric and Other Solid tumors
123456789.jpeg
CM313CD38(mAb)RRMM, lymphoma and  other hematological malignancies

Global
SLE

Global
CM355CD20xCD3
(Bispecific)
Lymphoma
hz3.pngGlobal
CM336BCMAxCD3
(Bispecific)
RRMM

Global
CM350GPC3xCD3
(Bispecific)
Solid tumors

Global
CM369CCR8Tumors
hz3.pngGlobal